180 related articles for article (PubMed ID: 17095751)
1. Long-term docosahexaenoic acid therapy in a congenic murine model of cystic fibrosis.
Beharry S; Ackerley C; Corey M; Kent G; Heng YM; Christensen H; Luk C; Yantiss RK; Nasser IA; Zaman M; Freedman SD; Durie PR
Am J Physiol Gastrointest Liver Physiol; 2007 Mar; 292(3):G839-48. PubMed ID: 17095751
[TBL] [Abstract][Full Text] [Related]
2. Cystic fibrosis fatty acid imbalance is linked to ceramide deficiency and corrected by fenretinide.
Guilbault C; Wojewodka G; Saeed Z; Hajduch M; Matouk E; De Sanctis JB; Radzioch D
Am J Respir Cell Mol Biol; 2009 Jul; 41(1):100-6. PubMed ID: 19059886
[TBL] [Abstract][Full Text] [Related]
3. Decreased peroxisome proliferator activated receptor alpha is associated with bile duct injury in cystic fibrosis transmembrane conductance regulator-/- mice.
Pall H; Zaman MM; Andersson C; Freedman SD
J Pediatr Gastroenterol Nutr; 2006 Mar; 42(3):275-81. PubMed ID: 16540796
[TBL] [Abstract][Full Text] [Related]
4. Characteristic multiorgan pathology of cystic fibrosis in a long-living cystic fibrosis transmembrane regulator knockout murine model.
Durie PR; Kent G; Phillips MJ; Ackerley CA
Am J Pathol; 2004 Apr; 164(4):1481-93. PubMed ID: 15039235
[TBL] [Abstract][Full Text] [Related]
5. Strain-dependent pulmonary gene expression profiles of a cystic fibrosis mouse model.
Haston CK; Cory S; Lafontaine L; Dorion G; Hallett MT
Physiol Genomics; 2006 Apr; 25(2):336-45. PubMed ID: 16614460
[TBL] [Abstract][Full Text] [Related]
6. Lung pathology in response to repeated exposure to Staphylococcus aureus in congenic residual function cystic fibrosis mice does not increase in response to decreased CFTR levels or increased bacterial load.
Davidson DJ; Webb S; Teague P; Govan JR; Dorin JR
Pathobiology; 2004; 71(3):152-8. PubMed ID: 15051928
[TBL] [Abstract][Full Text] [Related]
7. Induction of colitis in cftr-/- mice results in bile duct injury.
Blanco PG; Zaman MM; Junaidi O; Sheth S; Yantiss RK; Nasser IA; Freedman SD
Am J Physiol Gastrointest Liver Physiol; 2004 Aug; 287(2):G491-6. PubMed ID: 15064232
[TBL] [Abstract][Full Text] [Related]
8. Bioavailability and safety of a high dose of docosahexaenoic acid triacylglycerol of algal origin in cystic fibrosis patients: a randomized, controlled study.
Lloyd-Still JD; Powers CA; Hoffman DR; Boyd-Trull K; Lester LA; Benisek DC; Arterburn LM
Nutrition; 2006 Jan; 22(1):36-46. PubMed ID: 16226012
[TBL] [Abstract][Full Text] [Related]
9. Characterization of LPS-induced lung inflammation in cftr-/- mice and the effect of docosahexaenoic acid.
Freedman SD; Weinstein D; Blanco PG; Martinez-Clark P; Urman S; Zaman M; Morrow JD; Alvarez JG
J Appl Physiol (1985); 2002 May; 92(5):2169-76. PubMed ID: 11960971
[TBL] [Abstract][Full Text] [Related]
10. Lung disease in mice with cystic fibrosis.
Kent G; Iles R; Bear CE; Huan LJ; Griesenbach U; McKerlie C; Frndova H; Ackerley C; Gosselin D; Radzioch D; O'Brodovich H; Tsui LC; Buchwald M; Tanswell AK
J Clin Invest; 1997 Dec; 100(12):3060-9. PubMed ID: 9399953
[TBL] [Abstract][Full Text] [Related]
11. Detection of modifier loci influencing the lung phenotype of cystic fibrosis knockout mice.
Haston CK; McKerlie C; Newbigging S; Corey M; Rozmahel R; Tsui LC
Mamm Genome; 2002 Nov; 13(11):605-13. PubMed ID: 12461645
[TBL] [Abstract][Full Text] [Related]
12. Fatty acids in blood and intestine following docosahexaenoic acid supplementation in adults with cystic fibrosis.
Jumpsen JA; Brown NE; Thomson AB; Paul Man SF; Goh YK; Ma D; Clandinin MT
J Cyst Fibros; 2006 May; 5(2):77-84. PubMed ID: 16507353
[TBL] [Abstract][Full Text] [Related]
13. A membrane lipid imbalance plays a role in the phenotypic expression of cystic fibrosis in cftr(-/-) mice.
Freedman SD; Katz MH; Parker EM; Laposata M; Urman MY; Alvarez JG
Proc Natl Acad Sci U S A; 1999 Nov; 96(24):13995-4000. PubMed ID: 10570187
[TBL] [Abstract][Full Text] [Related]
14. Intestinal phenotype of variable-weight cystic fibrosis knockout mice.
Canale-Zambrano JC; Poffenberger MC; Cory SM; Humes DG; Haston CK
Am J Physiol Gastrointest Liver Physiol; 2007 Jul; 293(1):G222-9. PubMed ID: 17615178
[TBL] [Abstract][Full Text] [Related]
15. Ursodeoxycholate modulates bile flow and bile salt pool independently from the cystic fibrosis transmembrane regulator (Cftr) in mice.
Bodewes FA; Wouthuyzen-Bakker M; Bijvelds MJ; Havinga R; de Jonge HR; Verkade HJ
Am J Physiol Gastrointest Liver Physiol; 2012 May; 302(9):G1035-42. PubMed ID: 22301109
[TBL] [Abstract][Full Text] [Related]
16. Polyunsaturated fatty acid supplementation reverses cystic fibrosis-related fatty acid abnormalities in CFTR-/- mice by suppressing fatty acid desaturases.
Njoroge SW; Laposata M; Boyd KL; Seegmiller AC
J Nutr Biochem; 2015 Jan; 26(1):36-43. PubMed ID: 25448610
[TBL] [Abstract][Full Text] [Related]
17. Low linoleic and high docosahexaenoic acids in a severe phenotype of transgenic cystic fibrosis mice.
Strandvik B; O Neal WK; Ali MA; Hammar U
Exp Biol Med (Maywood); 2018 Mar; 243(5):496-503. PubMed ID: 29513100
[TBL] [Abstract][Full Text] [Related]
18. Changes in rat and mouse salivary glands and pancreas after chronic treatment with diuretics: a potential animal model for cystic fibrosis.
Sagström S; McMillan EB; Marijianowski M; Mulders H; Roomans GM
Scanning Microsc; 1990 Mar; 4(1):161-70; discussion 170. PubMed ID: 2367833
[TBL] [Abstract][Full Text] [Related]
19. Distinct pattern of lung gene expression in the Cftr-KO mice developing spontaneous lung disease compared with their littermate controls.
Guilbault C; Novak JP; Martin P; Boghdady ML; Saeed Z; Guiot MC; Hudson TJ; Radzioch D
Physiol Genomics; 2006 Apr; 25(2):179-93. PubMed ID: 16418321
[TBL] [Abstract][Full Text] [Related]
20. Instability of the insertional mutation in CftrTgH(neoim)Hgu cystic fibrosis mouse model.
Charizopoulou N; Jansen S; Dorsch M; Stanke F; Dorin JR; Hedrich HJ; Tümmler B
BMC Genet; 2004 Apr; 5():6. PubMed ID: 15102331
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
